Product Recalls in Rhode Island

Product recalls affecting Rhode Island — including food, drugs, consumer products, medical devices, and vehicles distributed to Rhode Island. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,521 recalls have been distributed to Rhode Island in the last 12 months.

47,970 total recalls
2,521 in last 12 months

Showing 72817300 of 13,384 recalls

DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Liothyronine Sodium USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Gabapentin USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Levothyroxine Sodium USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Medroxyprogesterone Acetate USP (Micronized) for prescription compounding...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Pentoxifylline USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Flurbiprofen USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Vancomycin HCl USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Naltrexone HCl USP (Dihydrate) for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Vardenafil HCl USP (trihydrate) for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Sumatriptan USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Levofloxacin Hemihydrate USP for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Clindamycin Phosphate USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Testosterone (Soy) (Micronized) USP for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Testosterone Enanthate USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Estrone USP for prescription compounding Recalled by American Pharmaceutical...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Lincomycin HCl USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Hydroxyprogesterone Caproate USP for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Lidocaine USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Ursodiol USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Cyclosporine USP Recalled by American Pharmaceutical Ingredients LLC Due to...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund